Efficacy and safety of cyclosporine versus tacrolimus in steroid and cyclophosphamide resistant nephrotic syndrome: A prospective study

INIS

• allocations 25%
• children 25%
• comparative evaluations 50%
• creatinine 25%
• cyclophosphamide 100%
• cyclosporine 100%
• diseases 25%
• drugs 50%
• gums 25%
• kidneys 50%
• patients 100%
• populations 25%
• safety 100%
• side effects 50%
• steroids 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Effect of Drug 22%
• Calcineurin Inhibitor 44%
• Ciclosporin 100%
• Congenital Nephrotic Syndrome 33%
• Creatinine 11%
• Cyclophosphamide 100%
• Diseases 11%
• Drug 11%
• Hyperplasia 11%
• Mycophenolate Mofetil 11%
• Nephrotic Syndrome 100%
• Prospective Study 100%
• Remission 33%
• Side Effect 22%
• Steroids 100%
• Survival 11%
• Tacrolimus 100%

Medicine and Dentistry

• Calcineurin Inhibitor 44%
• Chemotherapeutic Agent 11%
• Child 11%
• Childhood 11%
• Creatinine 11%
• Cyclophosphamide 100%
• Cyclosporine 100%
• Disease 11%
• Drug 11%
• Hyperplasia 11%
• Hypertrichosis 11%
• Inpatient 11%
• Kidney Function 11%
• Mycophenolate Mofetil 11%
• Nephrotic Syndrome 100%
• Patient 33%
• Serum 11%
• Side Effect 22%
• Spontaneous Remission 33%
• Steroid 100%
• Survival 11%
• Tacrolimus 100%
• Therapeutic Procedure 22%